Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
Source: https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-…
Intel appears to be on the verge of a long-awaited comeback. Uber’s valuation is near record lows as it maintains double-digit revenue growth.
AbbVie is a Dividend King poised to deliver solid growth. Chevron is well-positioned to capitalize on the new opportunities in Venezuela.
Investors have flocked to the safety of consumer staples stocks so far in 2026. Coca-Cola is about as consistent as they come in consumer goods.
